Kaplan–Meier survival analysis showed that high TAF12 expression was associated with shorter overall survival among glioma patients, and multivariate Cox analysis identified TAF12 as an independent poor prognostic factor in patients with glioma. Here, TAF12 is linked to central nervous system cancer.